AI Assistant
Blog
Pricing
Log In
Sign Up
P572 Reactive dose escalation of infliximab in patients with Crohn’s disease in TAILORIX leads to improved outcomes
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
